![](https://sdbig.com/wp-content/uploads/2023/08/medium-fFzFnX.jpeg)
With the company’s pandemic lift from the Covid-19 vaccine and drug sales over, Pfizer CEO Albert Bourla is betting on new drug approvals and deals.
San Diego Black Investors Group
With the company’s pandemic lift from the Covid-19 vaccine and drug sales over, Pfizer CEO Albert Bourla is betting on new drug approvals and deals.